See last night's digest, on your settings.

Real articles, found by Scienda in the last 36 hours. Nothing to sign up for, no email to give — change the settings and the list changes.

Quality bar — the journal's rank in its own field

Elite and above Top 5% and above Top 10% and above Top 25% and above Top 50% and above Any ranked and above

Article types — none ticked means all of them

clinical trial review guideline

12 articles matched your settings in the last 36 hours. Showing up to 3 per topic.

Stem Cell Transplant & Cellular Therapy 7 articles

Focused ultrasound for reshaping the immune microenvironment in glioblastoma

Journal of controlled release : official journal of the Controlled Release Society · Top 5% · review

Extracellular matrix-targeted TNC-scFv armoring enhances CAR T cell persistence and antitumor activity in solid tumors

Science advances · Top 5%

SUMO2 deletion changes chromatin accessibility and enhances cytotoxic T cell activation and tumor infiltration

Science advances · Top 5%

+ 4 more in this morning's digest.

Acute Myeloid Leukemia & Acute Leukemias 2 articles

Novel RNA polymerase I and cyclin-dependent kinase combination therapy for the treatment of aggressive acute myeloid leukemia

Leukemia · Top 5%

Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy

Leukemia · Top 5%

Anemia, RBC & Hemoglobinopathies 1 article

Sickle cell haemoglobin status shapes malaria parasite genotype in asymptomatic infections

Nature microbiology · Top 5%

Bone Marrow Failure & Benign WBC Disorders 1 article

Alkylating Agent-Induced FANCL Impairment Damages Pulmonary Arterial, Venous, and Microvascular Endothelial Cells and Predisposes to PAH/PVOD

Advanced science · Top 5%

Hemostasis & Thrombosis 1 article

Longitudinal sepsis-induced coagulopathy score trajectories and mortality in relation to early prophylactic heparin: a multicentre cohort study

Frontiers in cellular and infection microbiology · Top 10%

Get this in your inbox, every morning.

€4.50 / month or €45 / year · free trial — 14 days without a card, 30 days with · cancel any time

Start free — 14 days, no card or 30 days with a card full pricing

Titles, journals and ranks only — Scienda never republishes abstracts. Ranks come from the journal's percentile in its own field; how we rank.